HeartFlow Stock
Software for cardiovascular applications
About HeartFlow Stock
HeartFlow is a medical technology company that provides new methods of diagnosis and treatment of cardiovascular disease. It offers HeartFlow Analysis, a non-invasive solution available in the United States, Europe, and Japan that helps a physician evaluate whether a patient has significant coronary artery disease based on anatomy and physiology. Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 that became HeartFlow in May 2009. Its headquarters is in Redwood City in California.
Investors
Baillie Gifford
Spotify, AUTO1 Group, Ginkgo Bioworks, Carbon, Indigo AG, HeartFlow, Thumbtack, HelloFresh, Anaplan, Uptake Technologies
LifeForce Capital
Martis Capital
Wellington Management
Funding History
| July 2009 | $2.0M |
|---|---|
| August 2010 | $6.9M |
| August 2010 | $10.1M |
| December 2011 | $105M |
| January 2015 | $99.9M |
| November 2017 | $340M |
Management
Chief Executive Officer & President
Dana Mead
Co-Founder & Senior Vice President of Medical Affairs
Christopher K. Zarins
Co-Founder & Chief Technology Officer
Charles A. Taylor
Chief Financial Officer
Baird Radford
Chief Medical Officer
Campbell Rogers
Press
HeartFlow Announces FDA Clearance for HeartFlow Planner
businesswire - Sep, 12 2019
Use of HeartFlow Planner Leads to Change in Treatment Strategy in Nearly Half of Patients with Coronary Heart Disease
bioportfolio - May, 23 2019
Birmingham City Hospital turns to HeartFlow’s AI software to fight CHD
computerworlduk - Feb, 21 2019
HeartFlow publishes findings from consumer survey
massdevice - Feb, 8 2019
HeartFlow Survey: Fewer than 1/3 of Americans Know Biggest Health Threat
businesswire - Feb, 7 2019
HeartFlow Announces New Commercial Coverage With UnitedHealthcare, Largest Health Insurer in US
Business Wire (press release) - Jun, 27 2018
HeartFlow's AI coronary test outperforms conventional alternatives
VentureBeat - May, 22 2018
HeartFlow raises $240M to commercialize 3D heart model diagnosis technology
3ders.org (blog) - Feb, 16 2018
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from HeartFlow or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
